Treating CLL patients with Richter transformation

Role of Stem Cell Transplants in Richter's Transformation - Dr. Adam KittaiПодробнее

Epcoritamab Gives Deep Response in Richter’s TransformationПодробнее

The mutational profile in patients with CLL treated with acalabrutinib or ibrutinibПодробнее

Discussing the Unmet Clinical Needs in 2 Special CLL Patient Groups | Silvia Deaglio, MD | EHA 2024Подробнее

Dr Winter on Unmet Needs in Richter Transformation for Patients With CLLПодробнее

Evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in Richter's transformationПодробнее

A Phase II trial of pembrolizumab for Richter's transformation of CLLПодробнее

Chronic Lymphocytic Leukaemia (CLL) - New Study ResultsПодробнее

Designing Research Trials for Richter’s Transformation - Dr. Adam KittaiПодробнее

Triple Combination Therapy for Richter’s Transformation - Dr. Tamar Tadmor ASH 2023Подробнее

CHRONIC LYMPHOCYTIC LEUKEMIA Pathogenesis CLL Criteria Diagnosis TreatmentПодробнее

Novel treatment regimens under investigation for Richter's transformationПодробнее

Incidence of Richter’s Transformation in the Targeted Therapy Era - Dr. Paul Hampel ASH 2023Подробнее

Ibrutinib treatment for CLL does not increase the incidence of Richter’s transformationПодробнее

CAR T-Cell Therapy for Richter’s TransformationПодробнее

The management of Richter's transformation: current approaches and future outlooksПодробнее

Episode 097: Treatment of Relapsed/Refractory CLLПодробнее

Advice for community physicians managing Richter's transformation of CLLПодробнее

Pirtobrutinib for Richter's Transformation - Dr. William Wierda ASH 2023Подробнее

CAR-T Therapy for Richter Transformation - Dr. Adam Kittai ASH 2023Подробнее